Literature DB >> 17237400

Dendritic cell immunization route determines integrin expression and lymphoid and nonlymphoid tissue distribution of CD8 T cells.

Stacey L Sheasley-O'Neill1, C Colin Brinkman, Andrew R Ferguson, Melanie C Dispenza, Victor H Engelhard.   

Abstract

Exogenous dendritic cells (bone marrow-derived dendritic cell (BMDC)) display restricted trafficking in vivo after injection into mice, but the route(s) by which they generate gut-homing effector cells is unclear. Mesenteric lymph nodes (LN) and spleen were differentially targeted by i.p. and i.v. administration of BMDC, respectively, whereas mediastinal LN were targeted by both routes. BMDC injected by either route activated CD8(+) T cells to up-regulate both alpha(4)beta(1) and alpha(4)beta(7) integrins. However, the lymphoid compartment in which activation occurred determined their expression kinetics, magnitude, and population distribution. Only T cells activated in mesenteric LN after i.p. immunization expressed high levels of alpha(4)beta(7), which also correlated with localization to small intestine. These alpha(4)beta(7)(high) cells also redistributed to mediastinal LN in a manner sensitive to treatment with alpha(4)beta(7) blocking Abs, but not to mucosal addressin cell adhesion molecule-1 blocking Abs. Our results demonstrate the importance of lymphoid compartment, as dictated by immunization route, in determining integrin expression on activated T cells and their distribution in lymphoid and nonlymphoid tissues.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17237400      PMCID: PMC6046213          DOI: 10.4049/jimmunol.178.3.1512

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

Review 1.  Tissue targeting of T cells by DCs and microenvironments.

Authors:  Jan C Dudda; Stefan F Martin
Journal:  Trends Immunol       Date:  2004-08       Impact factor: 16.687

2.  The exit of lymphocytes and RBCs from the peritoneal cavity of sheep.

Authors:  W Andrade; M G Johnston; J B Hay
Journal:  Immunobiology       Date:  1996-01       Impact factor: 3.144

3.  Analysis of mouse dendritic cell migration in vivo upon subcutaneous and intravenous injection.

Authors:  M B Lappin; J M Weiss; V Delattre; B Mai; H Dittmar; C Maier; K Manke; S Grabbe; S Martin; J C Simon
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

4.  A cell-surface molecule involved in organ-specific homing of lymphocytes.

Authors:  W M Gallatin; I L Weissman; E C Butcher
Journal:  Nature       Date:  1983 Jul 7-13       Impact factor: 49.962

5.  Immune responses to the HLA-A*0201-restricted epitopes of tyrosinase and glycoprotein 100 enable control of melanoma outgrowth in HLA-A*0201-transgenic mice.

Authors:  D W Mullins; T N Bullock; T A Colella; V V Robila; V H Engelhard
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

6.  Regulation of thymocyte development through CD3: functional dissociation between p56lck and CD3 sigma in early thymic selection.

Authors:  C N Levelt; P Mombaerts; B Wang; H Kohler; S Tonegawa; K Eichmann; C Terhorst
Journal:  Immunity       Date:  1995-08       Impact factor: 31.745

7.  Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells.

Authors:  J Rodrigo Mora; Maria Rosa Bono; N Manjunath; Wolfgang Weninger; Lois L Cavanagh; Mario Rosemblatt; Ulrich H Von Andrian
Journal:  Nature       Date:  2003-07-03       Impact factor: 49.962

8.  Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues.

Authors:  Daniel J Campbell; Eugene C Butcher
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

9.  Administration route-dependent vaccine efficiency of murine dendritic cells pulsed with antigens.

Authors:  N Okada; M Tsujino; Y Hagiwara; A Tada; Y Tamura; K Mori; T Saito; S Nakagawa; T Mayumi; T Fujita; A Yamamoto
Journal:  Br J Cancer       Date:  2001-06-01       Impact factor: 7.640

10.  Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ.

Authors:  K Inaba; J P Metlay; M T Crowley; R M Steinman
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

View more
  21 in total

1.  Delivery route, MyD88 signaling and cross-priming events determine the anti-tumor efficacy of an adenovirus based melanoma vaccine.

Authors:  Basav N Hangalapura; Dinja Oosterhoff; Tarun Gupta; Jan de Groot; Pepijn G J T B Wijnands; Victor W van Beusechem; Joke den Haan; Thomas Tüting; Alfons J M van den Eertwegh; David T Curiel; Rik J Scheper; Tanja D de Gruijl
Journal:  Vaccine       Date:  2011-01-25       Impact factor: 3.641

2.  Reprogramming tumor-infiltrating dendritic cells for CD103+ CD8+ mucosal T-cell differentiation and breast cancer rejection.

Authors:  Te-Chia Wu; Kangling Xu; Romain Banchereau; Florentina Marches; Chun I Yu; Jan Martinek; Esperanza Anguiano; Alexander Pedroza-Gonzalez; G Jackson Snipes; Joyce O'Shaughnessy; Stephen Nishimura; Yong-Jun Liu; Virginia Pascual; Jacques Banchereau; Sangkon Oh; Karolina Palucka
Journal:  Cancer Immunol Res       Date:  2014-03-04       Impact factor: 11.151

Review 3.  Immune surveillance in melanoma: From immune attack to melanoma escape and even counterattack.

Authors:  Fade Mahmoud; Bradley Shields; Issam Makhoul; Nathan Avaritt; Henry K Wong; Laura F Hutchins; Sara Shalin; Alan J Tackett
Journal:  Cancer Biol Ther       Date:  2017-05-17       Impact factor: 4.742

Review 4.  Control of CD8 T-Cell Infiltration into Tumors by Vasculature and Microenvironment.

Authors:  J David Peske; Amber B Woods; Victor H Engelhard
Journal:  Adv Cancer Res       Date:  2015-06-01       Impact factor: 6.242

5.  T cells in the human metastatic melanoma microenvironment express site-specific homing receptors and retention integrins.

Authors:  Elise P Salerno; Walter C Olson; Chantel McSkimming; Sofia Shea; Craig L Slingluff
Journal:  Int J Cancer       Date:  2014-02-01       Impact factor: 7.396

Review 6.  Dendritic-cell-based therapeutic cancer vaccines.

Authors:  Karolina Palucka; Jacques Banchereau
Journal:  Immunity       Date:  2013-07-25       Impact factor: 31.745

Review 7.  Proposed mechanisms of action for prostate cancer vaccines.

Authors:  Sean M Geary; Caitlin D Lemke; David M Lubaroff; Aliasger K Salem
Journal:  Nat Rev Urol       Date:  2013-02-12       Impact factor: 14.432

8.  Peripheral tissue homing receptors enable T cell entry into lymph nodes and affect the anatomical distribution of memory cells.

Authors:  C Colin Brinkman; Sherin J Rouhani; Nithya Srinivasan; Victor H Engelhard
Journal:  J Immunol       Date:  2013-08-07       Impact factor: 5.422

9.  Lymphoid-tissue-specific homing of bone-marrow-derived dendritic cells.

Authors:  Rémi J Creusot; Shahriar S Yaghoubi; Pearl Chang; Justine Chia; Christopher H Contag; Sanjiv S Gambhir; C Garrison Fathman
Journal:  Blood       Date:  2009-04-10       Impact factor: 22.113

10.  Activated CD8 T cells redistribute to antigen-free lymph nodes and exhibit effector and memory characteristics.

Authors:  C Colin Brinkman; Stacey L Sheasley-O'Neill; Andrew R Ferguson; Victor H Engelhard
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.